NVS hasn’t sued Sun and probably doesn’t intend to. It’s reasonable to infer that Sun’s formulation of generic Gleevec doesn’t infringe NVS’ non-CoM patents.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”